NRX Pharmaceuticals Stock Forum

$NRX Pharmaceuticals (NRXP.US)$
FDA Approval scheduled on June 30th 2025
FDA Calendar – FDA Tracker

$NRX Pharmaceuticals (NRXP.US)$
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Alert Investors to Sanjay Gupta/CNN Program on Ketamine, Featuring Kadima Neuropsychiatry Institute Founder Dr. David Feifel
Tuesday, 14th January at 8:03 am
"'Special K': The Science & Stigma of Ketamine" on CNN, hosted by Dr. Sanjay Gupta
David Feifel MD PHD, Founder of Kadima, is a global thought leader in the interventional psychiatry field
Kadima Neuropsychiatry Institute identified as p...

$NRX Pharmaceuticals (NRXP.US)$ Reuters· 1 min ago
NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announces It Has Filed an Application With Nasdaq to Uplist to the Nasdaq Global Market From the Nasdaq Capital Market

$NRX Pharmaceuticals (NRXP.US)$
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces it has Filed an Application with NASDAQ to Uplist to the NASDAQ Global Market from the NASDAQ Capital Market
Monday, 13th January at 8:04 am
• Management believes uplisting has the potential to provide shareholders with improved liquidity
• Requires NRx Pharmaceuticals to meet certain listing requirements
• Company has advised NASDAQ that current shares outstanding is 15.7 million
WILMINGTON, Del., Jan. 13, 2...

$NRX Pharmaceuticals (NRXP.US)$ surprise us on red market make it 10$ jump😁😁

$NRX Pharmaceuticals (NRXP.US)$ that 4.9 is a good resisting level. if we break it. we will be good. I'm thinking $7 if we get to break it.

$NRX Pharmaceuticals (NRXP.US)$ will it break through 5$ AH or pre market?

$NRX Pharmaceuticals (NRXP.US)$
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Dr. Jonathan Javitt and Dr. David Feifel to Present Keynote Address, Beyond Ketamine Monotherapy: Combined Interventional Treatment of Suicidal Depression and PTSD, at the 8th Annual Neuroscience Innovation Forum in San Francisco
Tuesday, 7th January at 8:07 am
The Keynote Address, entitled "Beyond Ketamine: Combined Interventional Treatment of Suicidal Depression and PTSD," will be ...

$NRX Pharmaceuticals (NRXP.US)$
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Term Sheet for $27 Million in Funding for HOPE Clinic Acquisitions and Pharmaceutical Operations
Monday, 6th January at 10:16 am
Anticipated capital from funds managed by Smith & Sauer to augment potential bank-financing for acquisition of HOPE Therapeutics clinics and support NRx Pharmaceutical operations.
Purchase of $25 million in Series A Preferred Stock in HOP...

$NRX Pharmaceuticals (NRXP.US)$ 🚀🚀🚀